Suppr超能文献

不同尺寸的Amplatzer动脉导管封堵器(I型、II型和II AS型)对体重小于10公斤儿童的疗效比较。

Comparison of the efficacy of different-sized Amplatzer duct occluders (I, II, and II AS) in children weighing less than 10 kg.

作者信息

Baspinar Osman, Irdem Ahmet, Sivasli Ercan, Sahin Derya Aydin, Kilinc Metin

机构信息

Pediatric Cardiology Department, Gaziantep University Medical Faculty, 27310 Gaziantep, Turkey.

出版信息

Pediatr Cardiol. 2013 Jan;34(1):88-94. doi: 10.1007/s00246-012-0393-6. Epub 2012 May 31.

Abstract

The transcatheter closure of patent ductus arteriosus (PDA) may cause more complications in small children. Amplatzer (St. Jude Medical, Plymouth, MN) has produces three types of devices for ductal occlusion: the Amplatzer duct occluder I (ADO I) and II (ADO II) and the recently introduced ADO II additional sizes (ADO II AS). We performed this study to determine the efficacy and complication rates in children who weigh <10 kg for the three types of devices used in our clinic. Between February 2007 and March 2012, 77 patients weighing <10 kg had their PDAs occluded with ADOs. The mean age of the patients was 0.76 ± 0.44 years (range 17 days-2 years), and their mean weight was 6.73 ± 2.05 (range 1.2-9.9) kg. In total, 54 girls (70.1 %) and 23 boys (29.9 %) with a mean pulmonary ductus diameter of 2.55 ± 1.0 (1.08-5.94) mm were included in the study. The ADO I was used in 26 patients (33.8 %); the ADO II was used in 43 patients (55.8 %); and the ADO II AS was used in 8 patients (10.4 %). The mean ages of patients with the ADO I, ADO II, and ADO II AS were 1.07 ± 0.48, 0.66 ± 0.31, and 0.28 ± 0.17 years (p < 0.05), respectively. Their mean weights were 7.86 ± 1.45, 6.50 ± 1.85, and 4.36 ± 2.49 kg (p < 0.05), respectively. Their mean narrowest ductal diameters were 3.11 ± 0.96, 2.25 ± 1.06, and 2.33 ± 1.01 mm (p < 0.05), respectively. The use of the ADO II and ADO II AS was found to be more common in type C defects. One patient with the ADO I and 5 patients with the ADO II (7.8 %) developed varying degrees of left pulmonary artery stenosis or iatrogenic aortic coarctation. In 1 patient, the ADO II AS was replaced with the ADO II due to a significant residual shunt observed during the procedure. Each of the ADOs has its own advantages and disadvantages. Although the ADO I is convenient for medium- and large-sized defects, the ADO II and ADO II AS can be used both anterogradely and retrogradely. The ADO II AS is safe and efficient to use in small infants.

摘要

经导管闭合动脉导管未闭(PDA)在小儿中可能会引起更多并发症。美敦力公司(圣犹达医疗用品公司,明尼苏达州普利茅斯)生产了三种用于导管封堵的装置:Amplatzer动脉导管封堵器I型(ADO I)、II型(ADO II)以及最近推出的ADO II额外尺寸型(ADO II AS)。我们开展这项研究以确定在我们诊所中使用的这三种装置用于体重<10 kg儿童时的疗效和并发症发生率。2007年2月至2012年3月期间,77例体重<10 kg的患者使用ADO封堵了他们的动脉导管未闭。患者的平均年龄为0.76±0.44岁(范围17天至2岁),平均体重为6.73±2.05(范围1.2至9.9)kg。该研究共纳入54名女孩(70.1%)和23名男孩(29.9%),平均肺动脉导管直径为2.55±1.0(1.08至5.94)mm。26例患者(33.8%)使用了ADO I;43例患者(55.8%)使用了ADO II;8例患者(10.4%)使用了ADO II AS。使用ADO I、ADO II和ADO II AS的患者平均年龄分别为1.07±0.48、0.66±0.31和0.28±0.17岁(p<0.05)。他们的平均体重分别为7.86±1.45、6.50±1.85和4.36±2.49 kg(p<0.05)。他们的平均最窄导管直径分别为3.11±0.96、2.25±1.06和2.33±1.01 mm(p<0.05)。发现ADO II和ADO II AS在C型缺损中使用更为常见。1例使用ADO I的患者和5例使用ADO II的患者(7.8%)出现了不同程度的左肺动脉狭窄或医源性主动脉缩窄。在1例患者中,由于术中观察到明显的残余分流,将ADO II AS换成了ADO II。每种ADO都有其自身的优缺点。虽然ADO I适用于中大型缺损,但ADO II和ADO II AS可顺行和逆行使用。ADO II AS在小婴儿中使用安全且有效。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验